Literature DB >> 28365530

Regression of melanoma metastases and multiple non-melanoma skin cancers in xeroderma pigmentosum by the PD1-antibody pembrolizumab.

Axel Hauschild1, Julia Eichstaedt2, Lena Möbus2, Katharina Kähler2, Michael Weichenthal2, Thomas Schwarz2, Stephan Weidinger2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28365530     DOI： 10.1016/j.ejca.2017.02.026

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  14 in total

Review 1.  [Molecular genetic investigations as the basis for targeted treatment of basal cell carcinoma of the eye].

Authors:  L Boeckmann; M C Martens; V Kakkassery; L M Heindl; S Emmert
Journal:  Ophthalmologe       Date:  2020-02       Impact factor: 1.059

2.  Response to Pembrolizumab in a Patient With Xeroderma Pigmentosum and Advanced Squamous Cell Carcinoma.

Authors:  Angela Steineck; Niklas Krumm; Jay F Sarthy; Colin C Pritchard; Teresa Chapman; Andrew W Stacey; Nicholas A Vitanza; Bonnie Cole
Journal:  JCO Precis Oncol       Date:  2019-09-20

3.  Pembrolizumab treatment of a patient with xeroderma pigmentosum with disseminated melanoma and multiple nonmelanoma skin cancers.

Authors:  K H Kraemer; D Tamura; S G Khan
Journal:  Br J Dermatol       Date:  2018-05       Impact factor: 9.302

Review 4.  Systemic Immunotherapy for Advanced Cutaneous Squamous Cell Carcinoma.

Authors:  Dai Ogata; Tetsuya Tsuchida
Journal:  Curr Treat Options Oncol       Date:  2019-03-14

Review 5.  DNA repair defects and implications for immunotherapy.

Authors:  Katherine M Bever; Dung T Le
Journal:  J Clin Invest       Date:  2018-10-01       Impact factor: 14.808

Review 6.  Xeroderma pigmentosum: an updated review.

Authors:  Alexander Kc Leung; Benjamin Barankin; Joseph M Lam; Kin Fon Leong; Kam Lun Hon
Journal:  Drugs Context       Date:  2022-04-25

Review 7.  Understanding the Molecular Genetics of Basal Cell Carcinoma.

Authors:  Cristina Pellegrini; Maria Giovanna Maturo; Lucia Di Nardo; Valeria Ciciarelli; Carlota Gutiérrez García-Rodrigo; Maria Concetta Fargnoli
Journal:  Int J Mol Sci       Date:  2017-11-22       Impact factor: 5.923

Review 8.  Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?

Authors:  Anja Wessely; Theresa Steeb; Ulrike Leiter; Claus Garbe; Carola Berking; Markus Vincent Heppt
Journal:  Int J Mol Sci       Date:  2020-12-06       Impact factor: 5.923

Review 9.  Alterations of DNA damage repair in cancer: from mechanisms to applications.

Authors:  Minlin Jiang; Keyi Jia; Lei Wang; Wei Li; Bin Chen; Yu Liu; Hao Wang; Sha Zhao; Yayi He; Caicun Zhou
Journal:  Ann Transl Med       Date:  2020-12

10.  Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review.

Authors:  Marco Rubatto; Martina Merli; Gianluca Avallone; Andrea Agostini; Luca Mastorino; Virginia Caliendo; Amelia Barcellini; Viviana Vitolo; Francesca Valvo; Maria Teresa Fierro; Simone Ribero; Pietro Quaglino
Journal:  Oncotarget       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.